Role of peroxisome proliferator-activated receptor gamma and its ligands in non-neoplastic and neoplastic human urothelial cells
about
PPARgamma ligands inhibit primary tumor growth and metastasis by inhibiting angiogenesisCancer risk for patients using thiazolidinediones for type 2 diabetes: a meta-analysisThe antidiabetic drug ciglitazone induces high grade bladder cancer cells apoptosis through the up-regulation of TRAILPPARgamma-independent induction of growth arrest and apoptosis in prostate and bladder carcinomaSafety and tolerability of pioglitazone in high-risk patients with type 2 diabetes: an overview of data from PROactive.The investigation of mitogen-activated protein kinase phosphatase-1 as a potential pharmacological target in non-small cell lung carcinomas, assisted by non-invasive molecular imagingSpecific thiazolidinediones inhibit ovarian cancer cell line proliferation and cause cell cycle arrest in a PPARγ independent manner.DNA copy number alterations and PPARG amplification in a patient with multifocal bladder urothelial carcinoma.Risk of bladder cancer among diabetic patients treated with pioglitazone: interim report of a longitudinal cohort study.The use of pioglitazone and the risk of bladder cancer in people with type 2 diabetes: nested case-control study.14,15-Epoxyeicosatrienoic acid induces the proliferation and anti- apoptosis of human carcinoma cell.Association between longer therapy with thiazolidinediones and risk of bladder cancer: a cohort study.Deficiency in metabolic regulators PPARγ and PTEN cooperates to drive keratinizing squamous metaplasia in novel models of human tissue regeneration.Thiazolidinediones: potential as therapeutics for psoriasis and perhaps other hyperproliferative skin disease.A Role for the PPARgamma in Cancer Therapy.Rat Urinary Bladder Carcinogenesis by Dual-Acting PPARalpha + gamma AgonistsBasic evidence of molecular targeted therapy for oral cancer and salivary gland cancer.Pathology of bladder cancer among diabetic patients undergoing radical cystectomy with a history of pioglitazone (Actos) useWhen urothelial differentiation pathways go wrong: implications for bladder cancer development and progression.Scientific Evidence and Controversies About Pioglitazone and Bladder Cancer: Which Lessons Can Be Drawn?Loss of expression of the adipocyte-type fatty acid-binding protein (A-FABP) is associated with progression of human urothelial carcinomas.Pioglitazone and bladder cancer risk: a multipopulation pooled, cumulative exposure analysis.Thiazolidinedione drugs in the treatment of type 2 diabetes mellitus: past, present and future.Activation of peroxisome proliferator-activated receptor-gamma reverses squamous metaplasia and induces transitional differentiation in normal human urothelial cells.The PPARγ agonist Troglitazone induces autophagy, apoptosis and necroptosis in bladder cancer cells.Cloning and molecular dissection of the 8.8 kb pig uroplakin II promoter using transgenic mice and RT4 cells.Effect of peroxisome proliferator activated receptor gamma ligands on growth and gene expression profiles of gastric cancer cells.Insights on distinct pathways of thiazolidinediones (PPARgamma ligand)-promoted apoptosis in TRAIL-sensitive or -resistant malignant urothelial cells.Neoplastic and non-neoplastic changes in F-344 rats treated with Naveglitazar, a gamma-dominant PPAR alpha/gamma agonist.Risk of bladder cancer in diabetic patients treated with rosiglitazone or pioglitazone: a nested case–control study.Structurally diverse peroxisome proliferator-activated receptor agonists induce apoptosis in human uro-epithelial cells by a receptor-independent mechanism involving store-operated calcium channels.Urothelial carcinogenesis in the urinary bladder of rats treated with naveglitazar, a gamma-dominant PPAR alpha/gamma agonist: lack of evidence for urolithiasis as an inciting event.Peroxisome proliferator-activated receptor gamma in human prostate carcinoma.Urothelial carcinogenesis in the urinary bladder of male rats treated with muraglitazar, a PPAR alpha/gamma agonist: Evidence for urolithiasis as the inciting event in the mode of action.Pioglitazone Use and Risk of Bladder Cancer: an In Vitro Study.
P2860
Q24553314-BC02E7D3-1ACF-483F-93F0-BF248E840635Q27002540-5CC26223-F4B3-473B-A733-E8DBAC32F281Q28478349-FEE5342C-D84B-48A1-B3AC-22EA57E0244CQ33235601-7F2D1615-8F54-4C13-941C-518F52134D8BQ33425406-92A49B33-DD92-4426-9C00-800824F81019Q33540291-BED0E7EA-8F6A-4F3F-AB83-C473FBAD9697Q33809071-ABB4A03D-629E-49F5-BB7B-B39268731397Q34463194-A8D86121-5417-4444-AA28-C2AD127F4E2FQ34628009-1BE8E5D6-96DE-40F9-851D-54942A475FC3Q36001145-591E59FF-C45D-446D-854E-29CCA02EDAF1Q36215638-9EB1C50D-3DD8-47D5-B6FE-058F9A9C76ECQ36486802-85E5E5F2-ECB4-44DA-B1B4-79FC5CB17157Q36582849-6B18ADC1-5B8C-49F7-8046-447B4DB43786Q36623091-5D8A04CD-E07F-460C-85D1-E44B5618C2F9Q36691611-8130E76E-1F78-4ABD-90A9-D3F497E5DEE8Q37077098-C8ADEAD7-3189-472D-8329-ED53BEFA8759Q37144740-6719F798-DE51-4CB6-A022-3767420F84D4Q37607679-B1340BFA-85F9-430B-8C98-8AE68F59C093Q37933675-7167EBD9-C12B-4690-BB18-183110711CC5Q38122640-AF9CCA48-6D38-47A9-B15A-32941182E313Q38329996-F341558C-B48B-4231-A94F-57C63B10131FQ38417421-21F6D678-8919-4BF1-8B2E-4EE32AC39173Q38641190-882BAEE5-662B-4EEA-B549-1FAC750687B7Q38735354-EAA28223-E59F-4EA9-A1A1-D273BAF52C00Q38992608-570CDA75-10E4-44B0-8FB3-AC4C4AA8DB9CQ40291363-1B8845A5-F39D-4B39-819F-F1F0272FF626Q41892776-EDBBAFB5-28E6-4931-AE98-880796B53B5CQ43184836-B79AD911-52BA-4C33-B260-E6889703EA7EQ43287595-0606976C-22F9-4AAE-BB2E-4DE04CE50A05Q44980532-302C2C80-9BEF-410A-A673-3F6DC9AF5721Q45926666-1D575B1F-8F4E-4F12-8F92-965DC523AA92Q46599209-995FD65B-3F50-455A-B776-C08AB6B10D4CQ47829503-19CD2F63-5D71-4A18-9649-CDA668C1B660Q53338744-CCB968F3-6FBC-4479-9B26-F714578012AEQ55356554-36E4ABD6-1D2E-4BA0-9729-067C5C37747E
P2860
Role of peroxisome proliferator-activated receptor gamma and its ligands in non-neoplastic and neoplastic human urothelial cells
description
2001 nî lūn-bûn
@nan
2001 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Role of peroxisome proliferato ...... plastic human urothelial cells
@ast
Role of peroxisome proliferato ...... plastic human urothelial cells
@en
Role of peroxisome proliferato ...... plastic human urothelial cells
@nl
type
label
Role of peroxisome proliferato ...... plastic human urothelial cells
@ast
Role of peroxisome proliferato ...... plastic human urothelial cells
@en
Role of peroxisome proliferato ...... plastic human urothelial cells
@nl
prefLabel
Role of peroxisome proliferato ...... plastic human urothelial cells
@ast
Role of peroxisome proliferato ...... plastic human urothelial cells
@en
Role of peroxisome proliferato ...... plastic human urothelial cells
@nl
P2093
P2860
P1476
Role of peroxisome proliferato ...... plastic human urothelial cells
@en
P2093
A Chlenski
K I Nakashiro
T Tamatani
P2860
P356
10.1016/S0002-9440(10)61730-0
P407
P577
2001-08-01T00:00:00Z